1-1 of 1
Alfonso Quintαs-Cardama
Close
Sort by
Journal Articles

Modelling BCR-ABL1 Dynamics in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) during Frontline Therapy with High-Dose Imatinib, Nilotinib, or Dasatinib.

Adam Olshen, Alfonso Quintαs-Cardama, Hagop M. Kantarjian, Mithat Gonen, Franziska Michor, Jorge Cortes, MD
Journal: Blood
Blood (2008) 112 (11): 3240.
https://doi.org/10.1182/blood.V112.11.3240.3240
Published: 2008